Advertisement

Reactions Weekly

, Volume 1737, Issue 1, pp 106–106 | Cite as

Crizotinib

Liver dysfunction and gastrointestinal side effects: case report
Case report
  • 12 Downloads

Reference

  1. Zhu Y-C, et al. A novel co-existing ZCCHC8-ROS1 and de-novo MET amplification dual driver in advanced lung adenocarcinoma with a good response to crizotinib. Cancer Biology and Therapy 19: 1097-1101, No. 12, 2018. Available from: URL: http://doi.org/10.1080/15384047.2018.1491506 - ChinaCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations